MedTrace Logo

Lutronic PicoPlus Exploratory Clinical Trial

NCT03415685 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2023-12-20

Study results available
· View outcomes & findings →

Summary

This study will evaluate the use of the Lutronic PicoPlus for treatment of dermatological conditions such as unwanted tattoos and benign pigmented lesions.

Conditions

  • Tattoo; Pigmentation
  • Melasma
  • Benign Pigmented Lesion

Interventions

DEVICE

PicoPlus laser system

Laser treatment using specific pulse durations and wavelengths for selective pigment photothermolysis.

Sponsors & Collaborators

  • LUTRONIC Corporation

    lead INDUSTRY

Principal Investigators

  • Kari Larson, MBA · Sponsor GmbH

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2018-09-06
Completion
2018-10-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03415685 on ClinicalTrials.gov